Novel “ruthenium cyclopentadienyl”–peptide conjugate complexes against human FGFR(+) breast cancer
- 7 April 2020
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 49 (18), 5974-5987
- https://doi.org/10.1039/d0dt00955e
Abstract
Synthesis of the first half-sandwich ruthenium(ii)-cyclopentadienyl peptide conjugates and their biological evaluation against human FGFR(+) and FGFR(−) breast cancer cells.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/00100/2020, UID/Multi/04349/2019, CEECIND/00630/2017, SFRH/BD/135915/2018, CEECIND/02300/2017, UID/MULTI/04046/2019, PTDC/QUI-NUC/30147/2017, LISBOA-01-0145-FEDER-022125)
This publication has 61 references indexed in Scilit:
- Future directions for peptide therapeutics developmentDrug Discovery Today, 2013
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Studies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated LigandsBioinorganic Chemistry and Applications, 2010
- Structure validation in chemical crystallographyActa crystallographica. Section D, Structural biology, 2009
- Studies on anticancer activities of antimicrobial peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- Photophysical Properties of Ruthenium Bipyridine (4-Carboxylic acid-4‘-methyl-2,2‘-bipyridine) Complexes and Their Acid−Base ChemistryThe Journal of Physical Chemistry B, 2007
- Canonical sampling through velocity rescalingThe Journal of Chemical Physics, 2007
- Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibitionChemico-Biological Interactions, 1995
- A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP modelThe Journal of Physical Chemistry, 1993